Principal Financial Group
QTTB icon

Principal Financial Group’s Q32 Bio QTTB Stock Holding History

Principal Financial Group’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-581
Closed -$76K – 2627
2021
Q2 		$76K Buy
581
+23
+4% +$2.87K ﹤0.01% 2549
2021
Q1 		$95K Buy
+558
New +$118K ﹤0.01% 2427

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group's QTTB Position: Q3 2021 in Review

Principal Financial Group sold out of Q32 Bio (QTTB) in Q3 2021, closing a stake of 581 shares — an estimated $76K sold.

Principal Financial Group first reported a position in QTTB in Q1 2021 and held it in 2 quarters. The position peaked at $95K in Q1 2021. 119 funds tracked by Wall St. Rank hold QTTB as of Q3 2021.

  • Principal Financial Group reported no remaining Q32 Bio position as of Q3 2021 after selling out during the quarter.
  • Principal Financial Group sold 581 Q32 Bio shares in Q3 2021, an estimated $76K.
  • Principal Financial Group first reported a position in Q32 Bio in Q1 2021 and held it in 2 quarters.
  • Principal Financial Group's Q32 Bio position peaked at $95K in Q1 2021.
  • 119 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2021.

Based on Principal Financial Group's 13F filing for Q3 2021, filed 9 Nov 2021.